Theoretical Considerations
Asthma is generally regarded as belonging to the group of allergic or hypersensitivity reactions and is thought to be due to contraction of bronchiolar muscles in response to histamine liberated as a result of local antigen-antibody reactions. Mucosal oedema and hyperaemia and secretion of viscid mucus add to the bronchiolar obstruction. The promptness of the response of an asthmatic to an inhaled allergen is such that the asthmatic attack must be of the immediate rather than the delayed type of hypersensitivity reaction. Although cortisone inhibits the delayed type of sensitivity reaction in the skin (Long and Miles, 1950) , its effect upon the immediate type of skin reaction to injected allergens in sensitive subjects has been reported to be insignificant (Feinberg et Pickering, 1952; Lovell et al., 1953) . More recently, however, Holti (1.956) has shown that cortisone does reduce the skin reaction to injected histamine and Herxheimer (I954) has shown that the amount of an inhaled allergen necessary to cause an attack of asthma in sensitive subjects is considerably increased when they are under cortisone treatment. There is no convincing demonstration of an impairment of adrenal function in allergic subjects during attacks of asthma (Siegel et al., I956) , so that there is no reason to suppose that the use of these drugs in asthma may be regarded as replacement therapy; entirely unphysiological doses may be needed to produce an effect.
Clinical Reports
The literature on the treatment of asthma abounds with claims of success for innumerable methods which have later fallen into disuse after initial enthusiasm has worn off, or when control trials have shown them to be useless. This is partly because of the profound importance of psychological factors in inducing or relieving asthma and also because of the unpredictable course of the untreated disease. It is therefore necessary to be extremely cautious about accepting claims for the value of corticosteroids which, when they were first introduced, were hailed with uncritical enthusiasm as a cure for nearly all the ills to which mankind is heir and, more especially, as the solution to all the allergist's problems. Early reports on the use of these drugs in asthma were nearly all enthusiastic, but quite uncontrolled. The untoward side-effects and expense of prolonged administration were at first the only grounds for hesitation in accepting them as the treatment of choice in asthma. Subsequently, controlled trials, almost all carried out in Great Britain, have shown that the true place of corticosteroids in the treatment of asthma is limited. Since the effect of these drugs has been shown to be very different in acute attacks, in persistent asthma, and in asthma associated with other pulmonary diseases, the use of the drugs in these three types of case must be considered separately. Acute Asthmatic Attacks and Status Asthmaticus
The early uncontrolled claims of the effectiveness of corticosteroids in acute asthma (reviewed by Brown, I952) have been substantiated in this country by controlled trials of ACTH (Ball, 1954) Fig. 2 . The cortisone group showed significantly greater benefit than the control group from the second to the eighth week, but by the sixteenth week this difference had disappeared, and during the last 20 weeks of the trial the cortisone group were, if anything, less well off than the controls. (This may have been accounted for by the fact that some of the severer cases had been removed from the control group and transferred to corticosteroid therapy.) During the treatment period nine cortisone cases were withdrawn, five because of incidental illnesses, four of which (two psychoneuroses, one duodenal ulcer and one tuberculous kidney) may have been exacerbated by the cortisone. Two were withdrawn because of status asthmaticus and two defaulted. Ten control cases were withdrawn, five by default and five because of status asthmaticus. The conclusion is that cortisone is only of short-term benefit. The steady improvement of the control cases is notable and the fact that withdrawal of the control tablets was apparently as difficult as withdrawal of cortisone shows the powerful effect of suggestion on both patients and doctors. Fig. 3 shows that the exercise tolerance reported by the patients suggested a greater difference between treated and control groups than did the objective assessment. This is perhaps attributable to the psychological effect of cortisone. However, the effects on capacity for work were very little different in the two groups, nor was there any difference in the need for other treatment in the two groups. All but five cortisone and four control cases received other forms of anti-spasmodics throughout the trial.
The results of this trial have been described in some detail because of the very real doubt they throw upon the value of maintenance therapy by corticosteroids. They indicate the reality of temporary benefit, confined to the first two months of treatment, and they show how difficult it is to distinguish over longer periods between the benefits of cortisone and that of entirely ineffective tablets to hospital required ACTH because of failure to respond to routine treatment. These reports were made at a time when the drugs were in relatively short supply and may not be generally applicable today. It must be remembered that status asthmaticus is a dangerous condition which may be rapidly fatal and that response to corticosteroids may be delayed for two days, so that it is risky to wait for as long as 24 hours to see whether they may be required. In severe asthma I recommend that if, after four hours in hospital, adrenalin aerosol and intravenous aminophyllin have not produced a significant improvement, corticosteroids should be given.
It is more difficult to assess the need for these drugs in asthmatic attacks, which, while not severe enough to be a threat to life or even to demand admission to hospital, are nevertheless severely disabling. The first essential in such cases is to ensure full investigation to discover and remove possible environmental causes for the attack, whether psychological or allergic, and then to ensure that adequate anti-spasmodic therapy is being given. Some cases that are quite resistant to ephedrine may obtain relief from choline theophyllinate or to a combination of the two, and occasional cases are encountered who deny relief from a hand inhaler with adrenaline or isoprenaline, but who respond promptly when properly instructed in the use of the inha-ler. If, despite all such methods, -disabling asthma persists, then steroids should be tried, Since these drugs are potentially dangerous, especially in chronic cases, it is essential to ensure that any apparent benefit is really due to the drug itself. It may be due simply to an increase in morale from the psychological stimulus given by the drug. This confusion may be avoided by making objective measurements of ventilatory capacity in every case treated. Measurement of the one-second forced expiratory volume (FEV.1.0) (Gandevia and Hugh-Jones, 1957) There is little doubt that oral prednisolone is the drug of choice Jenkins, 1955; Sheldon et al., 1955) , although in an acute emergency it may be preceded by intravenous hydrocortisone to obtain a more rapid response. There are those who prefer to use intravenous ACTH on the grounds that the natural-steroids produced by the adrenal glands may be more effective than any single synthetic drug, but there is no clear evidence in support of this. There are certainly some cases which appear -to respond to ACTH after having failed on cortisone, but the reverse occurs equally frequently (Arbesman and Richards, I954; Bickerman and Barach, I954; Serafini and di Nardo, I955). There are others who like to combine ACTH with prednisolone or cortisone to avoid the atrophic effect of these drugs on the adrenal cortex (Arbesman and Richards, I954; Salassa et al., 1953; Taub et al., 1956 ). This is rather an elaborate way of avoiding a risk which is only encountered if the patient abruptly discontinues taking the drug, which need niever happen, and is, in any case, of doubtful importance (Henneman et al., I955). Whenever treatment is started it is best to begin with a large dose and then to reduce it over several days: 15 mg. of prednisolone may be given six-hourly at first and each dose may then be reduced by ing. every other day until 5 mg. are being giveni six-hourly. Thereafter the dose should be more slowly reduced to find the minimum required for relief of symptoms, and with the firm intention of discontinuing the drug if at all possible after 4ot more than three months, even though repeated courses may often be necessary in some cases. in the blood has proved difficult because of the large-amount of plasma required for estimations, but the method of Porter and Silber has become established.
Important progress in the scientific knowledge of cortisone metabolism has been made. It has been found that there is a diurnal variation in the level of blood hydrocortisone throughout the day in normal subjects. The mean value is high at 8 a.m., though in some people this is delayed till io a.m., and falls during the next four hours. After a short rise it falls again and is low between 4 p.m. and 6 p.m. Studies done throughout the night have shown a low level at 3 a.m., followed by a rise to the morning peak.
Investigations on rheumatoid patients have shown that the blood hydrocortisone is high, but that there are greater fluctuations throughout the day than in normal subjects.
Work on the physiological dispositions and metabolic fate of hydrocortisone in man have been carried out following intravenous infusion. In normal subjects the half life in plasma averaged I.9 hours. Following the infusion of tracer quantities of hydrocortisone -4-C I4 metabolites appears in the plasma in substantial quantity in two hours. Normal subjects excrete over 90 per cent. as urinary metabolites in 72 hours. Liver disease delays the excretion of hydrocortisone.
The Future
As the recent advances in the estimation of blood hydrocortisone levels continue it should soon be possible to adjust the dosage of the cortisones by scientific calculation instead of by balancing clinical improvement against side effects.
However, in spite of the somewhat crude regime which has, of necessity, ruled the dosage of cortisone and its analogues since their introduction in 1948, a large number of patie-nts who had failed to respond to other treatment and who were crippled with rheumatoid arthritis have been relieved of pain and enabled to return to work.
